NIH-funded research R21 grant

Understanding how host proteins affect alphavirus infections

Official title: Mechanisms of novel host factors in alphavirus infection

Funded at Albert Einstein College of Medicine · NIH-11096083 · Data updated 2026-11-12

This study is looking at how certain proteins in our bodies interact with alphaviruses, like the chikungunya virus, to help us understand how these viruses infect us and grow, which could lead to new treatments for people affected by these infections.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionAlbert Einstein College of Medicine
NIH-funded
Lab location1 site (Bronx, United States)
Project startJune 1, 2024
Project endApril 30, 2026
Funding year2025
Award (this year)$210,000
NIH project number5R21AI182834-02
Project IDNIH-11096083 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals who have been infected with alphaviruses or are at risk of such infections.

Less likely to help

Patients who are not affected by alphavirus infections or do not have a history of related viral diseases may not benefit from this research.

What this research studies

This research investigates the role of host proteins in the life cycle of alphaviruses, which include significant human pathogens like the chikungunya virus. By using innovative techniques such as biotinylation and mass spectrometry, the study aims to identify specific host proteins that interact with the virus during infection. This could lead to new insights into how the virus enters cells and replicates, ultimately informing the development of antiviral therapies. Patients may benefit from this research as it seeks to uncover potential targets for effective treatments against these viral infections.

Why it matters

Potential benefit: If successful, this research could lead to the development of new antiviral therapies for alphavirus infections.

How similar studies have gone: Other research has shown promise in identifying host factors in viral infections, suggesting that this approach could yield valuable insights.

Where this research is happening

  • Albert Einstein College of Medicine
    Bronx, United States
    Active

Researchers

  • Principal investigator: Martin, Caroline K — Albert Einstein College of Medicine
  • Study coordinator: Martin, Caroline K

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.